210 related articles for article (PubMed ID: 29426257)
1. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain.
Dutta L; Mukherjee B; Chakraborty T; Das MK; Mondal L; Bhattacharya S; Gaonkar RH; Debnath MC
Drug Deliv; 2018 Nov; 25(1):504-516. PubMed ID: 29426257
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB.
Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N
Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073
[TBL] [Abstract][Full Text] [Related]
3. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
[TBL] [Abstract][Full Text] [Related]
4. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
5. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
[TBL] [Abstract][Full Text] [Related]
6. Targeted SLNs for management of HIV-1 associated dementia.
Rai A; Jain A; Jain A; Jain A; Pandey V; Chashoo G; Soni V; Sharma PR
Drug Dev Ind Pharm; 2015; 41(8):1321-7. PubMed ID: 25113430
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanocarriers for Enhanced Delivery of Temozolomide to the Brain.
Khosa A; Krishna KV; Dubey SK; Saha RN
Methods Mol Biol; 2020; 2059():285-298. PubMed ID: 31435928
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
9. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
11. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
13. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
[TBL] [Abstract][Full Text] [Related]
16. Lipid Nanoformulations in the Treatment of Neuropsychiatric Diseases: An Approach to Overcome the Blood Brain Barrier.
Rehman S; Nabi B; Pottoo FH; Baboota S; Ali J
Curr Drug Metab; 2020; 21(9):674-684. PubMed ID: 32593280
[TBL] [Abstract][Full Text] [Related]
17. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies.
Yi T; Tang D; Wang F; Zhang J; Zhang J; Wang J; Xu X; Zhang J
Drug Deliv; 2017 Nov; 24(1):422-429. PubMed ID: 28165806
[TBL] [Abstract][Full Text] [Related]
18. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
19. Copper transport mediated by nanocarrier systems in a blood-brain barrier in vitro model.
Fehse S; Nowag S; Quadir M; Kim KS; Haag R; Multhaup G
Biomacromolecules; 2014 May; 15(5):1910-9. PubMed ID: 24725062
[TBL] [Abstract][Full Text] [Related]
20. Indinavir-Loaded Nanostructured Lipid Carriers to Brain Drug Delivery: Optimization, Characterization and Neuropharmacokinetic Evaluation.
Nasiri M; Azadi A; Zanjani MRS; Hamidi M
Curr Drug Deliv; 2019; 16(4):341-354. PubMed ID: 30674257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
